US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
BL

BLFS

$34.92
Sharia status
COMPLIANT
Per our secondary compliance provider · assessed 2026-08-12
HTR non-permissible income 0.06%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
⚪ NEUTRAL — No Edge
Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.
69
of 100
Setup confidence — system conviction, not win probabilityB
Trade plan SETUP
Entry
$35.19
Stop
$32.16
Target
$36.52
Risk : Reward 0.4R
Why this signal?
Structure2 of 5 timeframes bullish · 43.5% aligned
VWAPPrice below VWAP ($35.12)
VolumeRelative volume 5.4× the 20-day average
Momentum10-day rate of change -6.8%
Overall readNEUTRAL — No Edge

Biolife Solutions Inc (BLFS) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-12). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Wall Street consensus
HOLD
15 analysts
Institutional own.
106.4% *
of shares
Momentum (10d)
-6.8%
rate of change
SMC grade
B · 69
43.5% aligned
COMPLIANT
Sharia compliance
0.06%
Non-permissible income — HTR, from filings (2025-12-31)
B · 69
SMC grade — 43.5% timeframe alignment
-6.8%
Rate of change (10d)
HOLD
Wall Street consensus (15)
106.4%
Institutional ownership *

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for BLFS — this runs off the critical path so the page paints first. It will appear here on its own.

37.2232.4527.6922.9218.152025-09-112026-03-122026-09-10

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
33.49
S2
34.06
S1
34.49
PIVOT
35.06
R1
35.49
R2
36.06
R3
36.49

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
33.2581 38.6819
±7.54% from 35.97, made 2026-09-02 · resolves 2026-09-09
STRONG BUY
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22015 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

BUY
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesBUY
7 buy · 0 neutral · 5 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)50.30NEUTRAL
Stochastic %K (14)15.93BUY
CCI (20)-108.11BUY
Williams %R (14)-84.07BUY
MACD (12,26,9)-0.46SELL
ROC (10)-5.62SELL
Momentum (10)-2.08SELL
EMA (10)35.55SELL
SMA (10)35.80SELL
EMA (20)35.35SELL
SMA (20)36.03SELL
EMA (30)34.65BUY
SMA (30)35.17SELL
EMA (50)33.03BUY
SMA (50)32.80BUY
EMA (100)30.04BUY
SMA (100)28.48BUY
EMA (200)27.65BUY
SMA (200)25.61BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About Biolife Solutions Inc

Healthcare · Medical Instruments & Supplies

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

biolifesolutions.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-08-18

SETUP
Type
35.19
Entry
32.16
Stop
36.52
Target
LOSS
Outcome
Verdict

⚪ NEUTRAL — No Edge

Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.

Scores: 1 bullish / 1 bearish

Grade verdict

Good setup, solid confluence

SMC — Top Down

TimeframeBiasBars
📅 Daily BEARISH 62
⏰ 4H RANGING 36
🕐 1H RANGING 98
⏱ 15-Min BULLISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

0.61
MACD (no fresh cross)

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NEUTRAL   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.